News of Note—NovaVax, GeoVax and more

Here's some other vaccine news of note for this week.

> Looking to take on Sanofi's Fluzone HD, NovaVax is kicking off a phase 1/2 study of its NanoFlu candidate in older adults. Release

> GeoVax reported that its Zika vaccine candidate protected 100% of mice in a lethal challenge. Release

Survey

Veeva 2020 Unified Clinical Operations Survey

We believe you have the knowledge and expertise to make this year's Veeva 2020 Clinical Operations Report even more robust and insightful than the last. Please take a moment to share your opinion in this 10-minute survey. All qualified respondents will be entered to win a $500 Amazon gift card.

> CEL-SCI won a $1.5 million grant from the National Institutes of Health to work on a rheumatoid arthritis vaccine candidate. Release

> A team at Oregon State University isolated two proteins as promising candidates for a gonorrhea vaccine. Release

Read more on

Suggested Articles

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

Pfizer posted positive top-line results for a trial of its 20-valent pneumococcal vaccine, potentially setting up a filing by the end of 2020.

Univercells's new CDMO, Exothera, is hoping to play a role in helping drugmakers scale up manufacturing for a possible COVID-19 vaccine.